Lake Forest-based medical device maker Tenex Health Inc. said it recently received $5 million in private equity financing.

Tenex said it will use the money for manufacturing, sales and marketing.

The company makes a medical device that’s used to remove diseased tendon tissue and related musculoskeletal tissue.

The company said that it intends to use the device in the elbow, knee, ankle, foot and shoulder.

VCI Partners led the financing.

In a statement, Ivan Mijatovic, a VCI partner, said that his firm was “very impressed with the pace and focus of the management at Tenex Health.”

Tenex was established in 2009 and earlier received $1.7 million in seed funding.

Its device, the TX1, received Food and Drug Administration clearance in February and was introduced in May.

Marketing for additional uses such as plantar fascia, shoulder and Achilles tendon injuries are forthcoming, Tenex said.